Multicenter Retrospective Analysis of Cardiovascular Risk Factors Affecting Long-term Outcome of De Novo Cardiac Transplant Recipients

Journal of Heart and Lung Transplantation

Volumn 25, Issue 9, 2006, Pages 1063-1069

  Kobashigawa, Jon A ^a   Starling, Randall C ^b   Mehra, Mandeep R ^c   Kormos, Robert L ^d   Bhat, Geetha ^e   Barr, Mark L ^f   Sigouin, Chris S ^g   Kolesar, June ^g   Fitzsimmons, William ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF LOUISVILLE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DEFIBRILLATION; DIABETES MELLITUS; FEMALE; GRAFT FAILURE; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; KIDNEY DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TIME; VASCULAR DISEASE;

ADULT; AGED; BODY MASS INDEX; CARDIOVASCULAR PHYSIOLOGY; CREATININE; DIABETES COMPLICATIONS; FEMALE; GRAFT REJECTION; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 33748138829     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.05.001     Document Type: Article

References (32)

1. Taylor D.O., Edwards L.B., Mohacsi P.J., et al. The registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report-2003. J Heart Lung Transplant 22 (2003) 616-624
2. Valantine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant 23 suppl (2004) S187-S193
3. Costanzo M.R., Eisen J.H., Brown R.N., et al. Are there specific risk factors for fatal allograft vasculopathy?. An analysis of over 7,000 cardiac transplant patients. J Heart Lung Transplant 20 (2001) 152
4. Haji S.A., Starling R.C., Avery R.K., et al. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. J Heart Lung Transplant 23 (2004) 277-283
5. Kapadia S.R., Nissen S.E., Ziada K.M., et al. Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study. JAMA 38 (2001) 206-213
6. Kobashigawa J.A., Miller L., Yeung A., et al. Does acute rejection correlate with the development of transplant coronary artery disease?. A multicenter study using intravascular ultrasound (Sandoz/CVIS Investigators). J Heart Lung Transplant 14 suppl (1995) S221-S226
7. Day J.D., Rayburn B.K., Gaudin P.B., et al. Cardiac allograft vasculopathy: the central pathogenetic role of ischemia-induced endothelial cell injury. J Heart Lung Transplant 14 suppl (1995) S142-S149
8. Labarrere C.A., Pitts D., Nelson D.R., and Faulk W.P. Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients. N Engl J Med 333 (1995) 1111-1116
9. Dunn M.J., Crisp S.J., Rose M.L., Taylor P.M., and Yacoub M.H. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 339 (1992) 1566-1570
10. Hornick P., Smith J., Pomerance A., et al. Influence of acute rejection episodes, HLA matching, and donor/recipient phenotype on the development of 'early' transplant- associated coronary artery disease. Circulation 96 suppl (1997) II-148-53
11. Radovancevic B., Poindexter S., Birovljev S., et al. Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients. Eur J Cardiothorac Surg 4 (1990) 309-313
12. Escobar A., Ventura H.O., Stapleton D.D., et al. Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors. Am J Cardiol 74 (1994) 1042-1046
13. Kobashigawa J.A., Katznelson S., Laks H., et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 333 (1995) 621-627
14. Wenke K., Meiser B., Thiery J., et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation. Circulation 96 (1997) 1398-1402
15. Kwak B., Mulhaupt F., Myit S., and Mach F. Statins as a newly recognized type of immunomodulator. Nat Med 6 (2000) 1399-1402
16. Weitz-Schmidt G., Welzenbach K., Brinkmann V., et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 7 (2001) 687-692
17. Braith R.W., Mills R.M., Wilcox C.S., et al. High-dose angiotensin-converting enzyme inhibition restores body fluid homeostasis in heart-transplant recipients. JAMA 41 (2003) 426-432
18. Schroeder J.S., Gao S.Z., Alderman E.L., et al. A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med 328 (1993) 164-170
19. Mehra M.R., Ventura H.O., Smart F.W., et al. An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy. Am J Cardiol 75 (1995) 853-854
20. Hertz M.I., Taylor D.O., Trulock E.P., et al. The registry of the International Society for Heart and Lung Transplantation: nineteenth official report-2002. J Heart Lung Transplant 21 (2002) 950-970
21. Marelli S., Laks H., Patel B., et al. Heart transplantation in patients with diabetes mellitus in the current era. J Heart Lung Transplant 22 (2003) 1091-1097
22. Czerny M., Sahin V., Fashing P., et al. The impact of diabetes mellitus at the time of heart transplantation on long-term survival. Diabetologia 45 (2002) 1498-1508
23. Lang C.C., Beniaminovitz A., Edwards N., and Mancini D.M. Morbidity and mortality in diabetic patients following cardiac transplantation. J Heart Lung Transplant 22 (2003) 244-249
24. Kasiske B.L., Chakkera H.A., and Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 11 (2000) 1735-1743
25. John P.R., and Thuluvath P.J. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transplant 8 (2002) 708-713
26. Veillon S., Caillard S., Epailly E., et al. Chronic renal failure after cardiac transplantation: predictive factors and influence on mortality-results of a monocenter study in 141 patients. Transplant Proc 34 (2002) 2819-2820
27. Vossler M.R., Ni H., Toy W., and Hershberger R.E. Preoperative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation. J Heart Lung Transplant 21 (2002) 874-881
28. Lindelow B., Bergh C.H., Herlitz H., and Waagstein F. Predictors and evolution of renal function during 9 years following heart transplantation. J Am Soc Nephrol 11 (2000) 951-957
29. Satchithananda D.K., Parameshwar J., Sharples L., et al. The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience. J Heart Lung Transplant 2 (2002) 651-657
30. Esposito C., Semeraro L., Bellotti N., et al. Risk factors for chronic renal dysfunction in cardiac allograft recipients. Nephron 84 (2000) 21-28
31. Grady K.L., White-Williams C., Naftel D., et al., Cardiac Transplant Research Database (CTRD) Group. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices. J Heart Lung Transplant 18 (1999) 750-763
32. Lietz K., John R., Burke E.A., et al. Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Transplantation 72 (2001) 277-283